Peripheral T-cell lymphoma (PTCL) - brentuximab vedotin - initial authority application form (PB314)

Use this form to apply for initial PBS-subsidised treatment with brentuximab vedotin for peripheral T-cell lymphoma.

Page last updated: 1 June 2025.
QC 55346